About Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Bacteria-Eating Viruses to be Used in the War on Superbugs

by Kathy Jones on October 18, 2013 at 5:20 PM
Font : A-A+

 Bacteria-Eating Viruses to be Used in the War on Superbugs

Viruses that eat bacteria have been isolated to specifically target the highly infectious hospital superbug Clostridium difficile by a specialist team of scientists from the University of Leicester.

Now an exciting new collaboration between the University of Leicester, the University of Glasgow and AmpliPhi Biosciences Corporation could lead to the use of bacteriophages for treating the superbug Clostridium difficile infections.

Advertisement

Dr Martha Clokie, from the University of Leicester's Department of Infection, Immunity and Inflammation has been investigating an alternative approach to antibiotics, which utilizes naturally occurring viruses called bacteriophages, meaning 'eaters of bacteria'.

The work has predominantly been funded by the Medical Research Council (MRC).

Dr Clokie said: "Ever since the discovery of the first antibiotic, penicillin, antibiotics have been heralded as the 'silver bullets' of medicine. They have saved countless lives and impacted on the well-being of humanity.
Advertisement

"But less than a century following their discovery, the future impact of antibiotics is dwindling at a pace that no one anticipated, with more and more bacteria out-smarting and 'out-evolving' these miracle drugs. This has re-energised the search for new treatments.

"One alternative to antibiotics is bacteriophages, known as phages, which unlike antibiotics, are specific in what they kill and will generally only infect one particular species, or even strain, of bacteria - referred to as the 'host'. Following attachment to their hosts, they inject their DNA into the bacterium, which then replicates many times over, ultimately causing the bacterial cell to burst open. The phages released from the dead bacterium can then infect other host cells."

Dr. Clokie and her team have achieved the remarkable feat of isolating and characterising the largest known set of distinct C. diff phages that infect clinically relevant strains of C. diff. Of these, a specific mixture of phages have been proved, through extensive laboratory testing, to be effective against 90% of the most clinically relevant C. diff strains currently seen in the U.K.

As a testament to their therapeutic potential, these phages, that are the subject of a patent application, have been licensed by AmpliPhi Biosciences Corporation - a US-based biopharmaceutical company and pioneers in developing phage-based therapeutics. AmpliPhi have already made progress in developing phages targeted against Pseudomonas aeruginosa, a pathogen that causes acute, life-threatening lung infections in cystic fibrosis patients. They were also the first biopharmaceutical company to demonstrate the effectiveness of Pseudomonas phages in controlled and regulated human clinical trials.

As part of this exciting collaboration, AmpliPhi are funding further development and testing of C. diff phages developed by Dr. Clokie. The goal is to have a phage mixture ready to go into phase 1 and 2 clinical trials. This will involve optimising phage-preparations for maximum efficacy against C. diff infections from around the globe and establishing production, storage and delivery systems for the phage mixture. Evaluations of the efficacy of bacteriophage therapy and optimisation of dosing regimes will be carried out in collaboration with the University of Glasgow, in the laboratory of Dr Gill Douce.



Source: Eurekalert
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
Prevent Hacking of Medical Devices: FDA Sounds Alarm
Black Water: Benefits and Uses
World Hypertension Day 2022 - Measure Blood Pressure Accurately, Control It, Live Longer!
View all
News Archive
Date
Category
Advertisement
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

Most Popular on Medindia

Hearing Loss Calculator Iron Intake Calculator Accident and Trauma Care Vent Forte (Theophylline) Color Blindness Calculator Drug Interaction Checker Daily Calorie Requirements Blood Donation - Recipients Find a Doctor Noscaphene (Noscapine)

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2022

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use